-
Loading metrics
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
- Jochen Dutzmann,
- Robert-Jonathan Musmann,
- Marco Haertlé,
- Jan-Marcus Daniel,
- Kristina Sonnenschein,
- Andreas Schäfer,
- Peter Kolkhof,
- Johann Bauersachs,
- Daniel G. Sedding
x
- Published: September 19, 2017
- https://doi.org/10.1371/journal.pone.0184888